StocksFin Logo
Rhythm Pharmaceuticals, Inc. country of incorporation
|
|
Mr. Hunter Smith
|
140 employees
NASDAQ | Healthcare | Biotechnology
Profound Medical Corp. country of incorporation
|
|
Dr. Arun Swarup Menawat
|
146 employees
NASDAQ | Healthcare | Medical Devices
Q322 reported Nov 8, 2022 Reporting Period
$4.28M 316.7% vs. Q321 Revenues Q322
88.4% 12.7% vs. Q321 Gross Profit Margin
-953.8% ! 4.6% vs. Q321 Net Profit Margin
-47.08M ! -17.2% vs. Q321 Free Cash Flow Q322
$-0.79 ! -12.9% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Q322 reported Sep 30, 2022 Reporting Period
$2.04M -19.8% vs. Q321 Revenues Q322
53.56% 37.7% vs. Q321 Gross Profit Margin
-245.55% ! -3.9% vs. Q321 Net Profit Margin
-5.76M ! -14.7% vs. Q321 Free Cash Flow Q322
$-0.24 ! 17.2% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Sep 30, 2022
Quick Ratio
10.61
14.98
Current Ratio
10.93
17.36
Cash Ratio
5.59
13.93
Price to Book
4.48
1.4
Price to Sales
100
41.4
Price to Earnings
-7.7
-4.22